Thus, it cannot be ruled out that biochemical processes leading to the development and intensification of OM in patients undergoing RTH due to HNC do not result from the disturbance of TNF-α but of its receptor TNFR1 responsible for the apoptotic pathway. The gene discussed is TNFRSF1A; the disease is ocular melanoma.